Replies to post #13561 on CV Sciences Inc (CVSI)

[Vandalayind]

From last financial.


"We expect to realize revenue from our consumer products business segment to fund our working capital needs during 2018. The Company’s pharmaceutical business segment may require additional capital over the next 12 months. Management believes that it will be able to fund our drug development efforts in 2018 either through current cash flow, or, through external financing on terms acceptable to the Company, however, there can be no assurances that the Company will be successful. If the Company is unable to generate sufficient cash flow or raise additional capital, the Company would likely be forced to curtail pharmaceutical development."

[CashMoneyCarl]

I guess the point is the reverse will be done in order to raise money through equity issues while controlling the MCAP.

I see your point, and it actually valid.

[jefra1965]

I cant't believe we are still stuck in this R/S issue. For those worry about that OPTION let me tell you; you don't know what you own.
I would like to see who is going to sell when this OTC company developes a P/E of 83.33 = ($5.00/0.06), a FCF of 18-20% and NO DEBT by next FY 10-K report (early April 2019)
I will do what I do all the time. I will follow the money. I just hope CVSI keeps performing well..
And if you are too sick about the R/S, just sell and don't suffer anymore, (move on) go back to trying & find a great stock in the OTC with all CVSI's potential...

Good Luck and MOVE ON...